DJ Sana Biotechnology Shares Continue to Climb in Second Trading Day >SANA
By Colin Kellaher
Shares of Sana Biotechnology Inc., which rose more than 40% in their trading debut Thursday after the cellular-engineering startup's initial public offering, tacked on further gains in early trading Friday.
Sana shares were recently trading at $39.22, up 11.7%.
The Seattle company, which is developing cell-engineering platforms that use gene and cell therapy to treat diseases such as cancer, diabetes and central-nervous-system disorders, sold 23.5 million shares at $25 apiece in an upsized initial public offering was priced above already increased expectations.
The stock opened at $35 on Thursday and peaked at $38.45 before closing at $35.10, for a first-day gain of 40.4%.
Write to Colin Kellaher at email@example.com
(END) Dow Jones Newswires
February 05, 2021 10:59 ET (15:59 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.